Veradermics MANE
NYSE MANE
$127.10 +4.82 (+3.94%)
As of: Oct 20, 2026 · 3:59 PM EDT

Veradermics (MANE) Operating Expenses (2025 - 2026)

Updated

Veradermics (MANE) recorded Operating Expenses of $29.55 million in Q2 2026, up 83.9% from $16.07 million a year earlier but down 1.0% from the prior quarter.

Analysis

Veradermics (MANE) Operating Expenses (2025 - 2026) Analysis & Trends

On a TTM basis, Veradermics' Operating Expenses came in at $88.4 million as of Jun 30, 2026; for FY2025, it came in at $72.35 million, up 170.2% from FY2024.

  • Across earlier years, Operating Expenses came in at $26.78 million in FY2024.
  • Quarterly Operating Expenses has ranged from $12.92 million in Q1 2025 to $29.86 million in Q1 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 10.12 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 10.56 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 9.70 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 18.20 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 6.68 Bn
10 Veradermics 5.17 Bn 3.77 Bn - 29.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.55 Mn
Mar 31, 2026 29.86 Mn
Jun 30, 2025 16.07 Mn
Mar 31, 2025 12.92 Mn
API Access

Veradermics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=MANE&period=max&api_key=YOUR_API_KEY